Two Asian regulators take recall action over plasticisers in Augmentin formulations
This article was originally published in Scrip
Executive Summary
Drug regulatory authorities in Hong Kong and Taiwan have ordered recalls of flavoured paediatric formulations of GlaxoSmithKline's antibacterial Augmentin (amoxicillin clavulanate) after they were found to contain trace amounts of plasticising agents.